IL111393A0 - New ribosome-inactivating protein isolated from the plant byronia dioica - Google Patents

New ribosome-inactivating protein isolated from the plant byronia dioica

Info

Publication number
IL111393A0
IL111393A0 IL11139394A IL11139394A IL111393A0 IL 111393 A0 IL111393 A0 IL 111393A0 IL 11139394 A IL11139394 A IL 11139394A IL 11139394 A IL11139394 A IL 11139394A IL 111393 A0 IL111393 A0 IL 111393A0
Authority
IL
Israel
Prior art keywords
plant
protein isolated
inactivating protein
new ribosome
byronia
Prior art date
Application number
IL11139394A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL111393A0 publication Critical patent/IL111393A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • A61K47/6819—Plant toxins
    • A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL11139394A 1993-10-25 1994-10-25 New ribosome-inactivating protein isolated from the plant byronia dioica IL111393A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14189193A 1993-10-25 1993-10-25
US08/324,301 US5597569A (en) 1993-10-25 1994-10-20 Bryodin 2 a ribosome-inactivating protein isolated from the plant Bryonia dioica

Publications (1)

Publication Number Publication Date
IL111393A0 true IL111393A0 (en) 1995-03-30

Family

ID=26839543

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11139394A IL111393A0 (en) 1993-10-25 1994-10-25 New ribosome-inactivating protein isolated from the plant byronia dioica

Country Status (7)

Country Link
US (1) US5597569A (xx)
EP (1) EP0725823A1 (xx)
JP (1) JPH09509043A (xx)
AU (1) AU684571B2 (xx)
CA (1) CA2174943A1 (xx)
IL (1) IL111393A0 (xx)
WO (1) WO1995011977A2 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU701302B2 (en) * 1994-05-13 1999-01-21 Merck Patent Gesellschaft Mit Beschrankter Haftung Improvements in or relating to peptide delivery
US5541110A (en) * 1994-05-17 1996-07-30 Bristol-Myers Squibb Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica
US6410690B1 (en) 1995-06-07 2002-06-25 Medarex, Inc. Therapeutic compounds comprised of anti-Fc receptor antibodies
IT1286663B1 (it) * 1996-06-27 1998-07-15 Ministero Uni Ricerca Scient E Proteina capace di inibire l'attivita' ribosomiale,sua preparazione ed uso come immunoconiugato chimico o ricombinante e sequenza di cdna
WO1998055623A1 (en) 1997-06-06 1998-12-10 Tanox Pharma B.V. Type-1 ribosome-inactivating protein
DE19740180A1 (de) * 1997-09-12 1999-03-18 Basf Ag Katalysator, umfassend wenigstens einen Nickel(0)Komplex auf Basis eines Phosphonitliganden und Verfahren zur Herstellung von Nitrilen
US6251392B1 (en) * 1997-10-20 2001-06-26 Epicyte Pharmaceuticals, Inc. Epithelial cell targeting agent
JP2002522559A (ja) * 1998-08-11 2002-07-23 ラージ スケール バイオロジー コーポレイション 植物組織の間質液からタンパク質を回収するための方法
US6946129B1 (en) * 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
US20010051147A1 (en) * 2000-03-27 2001-12-13 Van De Winkel Jan G.J. Methods for immunostimulation using binding agents for the Fc receptor of immunoglobulin A
US7491702B2 (en) * 2001-04-18 2009-02-17 The Open University Polypeptides related to amyloid precursor protein, pharmaceutical compositions thereof, and methods of treatment using the same
US7622446B2 (en) * 2001-04-18 2009-11-24 The Open University Polypeptides, derivatives and uses thereof
MXPA06009759A (es) * 2004-02-27 2007-03-26 Pacmab Ltd Codocito para trastornos por linfocitos b.
AU2006249305B2 (en) 2005-05-26 2012-10-18 Genentech, Inc. Humanized anti-CD40 antibodies and their methods of use
EP2195346B1 (en) 2007-08-30 2018-01-03 The Walter and Eliza Hall Institute of Medical Research Dendritic cell marker and uses thereof
US8530628B2 (en) 2007-09-28 2013-09-10 Welcome Receptor Antibodies Pty Ltd Diagnosis and treatment of diseased and damaged tissue
SG11201408280YA (en) * 2012-06-26 2015-01-29 Biovalence Sdn Bhd Anticancer treatment
CA2877272A1 (en) * 2012-06-26 2014-01-03 Biovalence Sdn. Bhd. Dosage regime of fusion compounds
WO2023196892A1 (en) 2022-04-06 2023-10-12 The Trustees Of The University Of Pennsylvania Passive immunization with anti- aav neutralizing antibodies to prevent off-target transduction of intrathecally delivered aav vectors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8619830D0 (en) * 1986-08-14 1986-09-24 Erba Farmitalia Inhibitor of protein synthesis
NL8701095A (nl) * 1987-05-08 1988-12-01 Nido Universal Machines Bv Loopwiel voor een strooi-inrichting.
IT1229216B (it) * 1989-03-31 1991-07-25 Italfarmaco Spa Proteine inibenti i ribosomi e loro derivati.
IL94872A (en) * 1989-06-30 1995-03-30 Oncogen Monoclonal or chimeric antibodies that react with human carcinoma, recombinant proteins that contain their anti-binding site, pharmaceutical preparations and kits that contain the
US5242813A (en) * 1990-10-12 1993-09-07 The United States Of America As Represented By The Department Of Health And Human Services Mouse monoclonal antibodies specific for normal primate tissue, malignant human cultural cell lines human tumors

Also Published As

Publication number Publication date
EP0725823A1 (en) 1996-08-14
AU684571B2 (en) 1997-12-18
WO1995011977A2 (en) 1995-05-04
JPH09509043A (ja) 1997-09-16
CA2174943A1 (en) 1995-05-04
WO1995011977A3 (en) 1995-05-26
AU8094594A (en) 1995-05-22
US5597569A (en) 1997-01-28

Similar Documents

Publication Publication Date Title
GB2269176B (en) Peptides
IL111393A0 (en) New ribosome-inactivating protein isolated from the plant byronia dioica
GB9507319D0 (en) Plant tender
EP0701446A4 (en) HEMOREGULATORS PEPTIDES
BG98899A (en) Pesticides
EP0578819A4 (en) Icam-related protein.
PL309778A1 (en) Novel peptides
IL110938A0 (en) Plant proteins
EP0679658A4 (en) PEPTIDE WITH ANTAGONIST EFFECT OF ENDOTHELIN.
GB9325519D0 (en) Peptides
IL108353A0 (en) Novel peptides
GB9320930D0 (en) Modified fruit
ZA941081B (en) Pesticides
GB2279703B (en) Variable area outlet
ZA934353B (en) Linear peptides.
GB9204274D0 (en) Novel peptides
EP0561439A3 (en) Ersions
EP0725651A4 (en) HEMOREGULATORS PEPTIDES
GB9313891D0 (en) Pesticides
ZA944947B (en) Pesticides
EP0672680A4 (en) NEW PEPTID.
KR960007545Y1 (en) Outlet trap
ZA935126B (en) Peptides
GB9210074D0 (en) Peptides
ZA944337B (en) Peptides